Current NHS consultant posts held
Mid and South Essex University NHS Hospitals
Research interests
Spinal cord stimulation for neuropathic, ischaemic and visceral pain
Investigating clinical and cost effectiveness of interventional pain medicine using randomised comparison trial methodology
Long term observational studies using registry databases
Investigational work of mechanisms of action of neurostimulation
Multifidus nerve stimulation for severe refractory low back pain
More citations
Eldabe S., Thomson S. et al. The effectiveness and cost effectiveness od spinal cord stimulation for refractory angina (RASCAL study): A pilot RCT. Neuromodulation 2016; 19: :60-70Provenzano D., Thomson S. et alAn International Survey to understand infection control practices for SCS. Neuromodulation 2016; 19: 71 – 84
Deer TD., Thomson S. et al PACC: Recommendations for Trialing of ITDD Neuromodulation 2017; 20: 133–154Deer TD., Thomson S et al NACC Recommendations for Infection Prevention and Management Neuromodulation 2017; 20: 31–50
Personal interests
Teaching
Research
President of International neuromodulation society 2009 - 2015
Consultancy work for innovation in neuromodulation field
Awards received
Emeritus Director at Large of International Neuromodulation Society
Publications
May. M.,Thomson. S et al: A retrospective, long term, third party follow up of patients considered for spinal cord stimulation. Neuromodulation 2002 vol 5 No. 3 p.137 – 144
Buchser E., Thomson S. The future of spinal cord stimulation and other related neuroaugmentative procedures. Electrical stimulation and the relief of pain. Edited by Brian Simpson. 2003
Kumar, K., Thomson., S. et al Spinal Cord Stimulation versus Conventional Medical Management for Neuropathic Pain: A Multicenter Randomized Controlled Trial in Patients with Failed Back Surgery Syndrome. Pain 2007’132:179-188
Spinal cord stimulation in Clinical pain management Hodder published 2008
Kumar, K., Thomson et al The effects of spinal cord stimulation in neuropathic pain are sustained: A 24 month follow up of the prospective randomized controlled multicenter trial of the effectivenss of spinal cord stimulation. Neurosurgery 2008; 63: 4; 762-770
Thomson S., Jacques L Demographic characteristics of patients with severe neuropathic pain secondary to failed back surgery syndrome. Pain Practice 2009;9:206-214
Rudiger J., Thomson S. Infection rate of spinal cord stimulators after a screening trial period. A 53 month follow up. Neuromodulation 2011;14: 136 -141
Eldabe S., Thomson S, Baranidharan G. Variation in spinal cord commissioning:What does the Hospital Episode Statistics database tell us? Pain News 2012 :10: 94 – 96
Thomson S., Taylor R. Value of pilots and the need to choose the right comparator. BJA 2012: 109 (4) 485-486
Eldabe S, Thomson S et al
The effectiveness and cost effectiveness of spinal cord stimulation for refractory angina (RASCAL study): study protocol for a pilot randomized controlled trial
Trials 2013,14;57http://www.trialsjournal.com/conten/14/1/57
Thomson S. Failed Back Surgery Syndrome – definition, epidemiology and demographics. British Journal of Pain 2013; 7,(1) 56 -59
Rezai A., Thomson S. et al Physician response to Medtronic’s position on the use of Off-Label medications in the Synchromed pump. Pain Physician 2013; 16: 415 – 417 and Neuromodulation 2013; 16:398-400Deer T., Thomson S. et al International Neuromodulation Society Critical Assessment:  Guideline Review of Implantable Neurostimulation Devices Neuromodulation 2014; 17Deer T., Thomson S et al. NACC: Avoidance and Treatment of complications of neurostimulation therapies for the treatment of chronic pain. Neuromodulation 2014; 17:
Launch
Website
